The Safety of High Dose Labetalol in the Pregnant Population

Hypertension in pregnancy is one of the leading causes of maternal mortality and rapid treatment is critical. Treatment of emergent hypertensive crises in pregnancy is limited to only three medications, one of which is labetalol. Current literature recommends a daily maximum intravenous labetalol dose of 300 mg per day. However, this maximum dose has not been studied in pregnancy where higher doses may be required.

Labetalol Hydrochloride Tablets, USP 100 mg, 200 mg and 300 mgRx only

Management of Women With Acquired Cardiovascular Disease From Pre-Conception Through Pregnancy and Postpartum: JACC Focus Seminar 3/5 - ScienceDirect

PDF) Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: A systematic review and meta-analysis

Drugs in Gestational Hypertension – The Early Career Voice

Healthcare, Free Full-Text

Oral nifedipine vs. intravenous labetalol for treatment of pregnancy‐induced severe pre‐eclampsia - Shi - 2016 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library

LABETALOL HYDROCHLORIDE tablet, film coated

Labetalol Hydrochloride Tablets, USP 100 mg, 200 mg and 300 mgRx only

Labetalol Hydrochloride Injection USP Taj Pharma SmPC by QC TAJ PHARMA - Issuu

Obstetric and Fetal Pharmacology, Article

Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial - The Lancet